Troubles neurocognitifs chez les personnes âgées avec maladie oncologique [Cancer-related cognitive impairment in older adults]
Fiche du document
11 novembre 2020
- doi: 10.53738/REVMED.2020.16.714.2172
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.714.2172
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33174700
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_39869DBCE90B9
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Physical handicaps Handicaps Disabling conditions Impairment Physical disabilities DisabilityCiter ce document
L. Baratali et al., « Troubles neurocognitifs chez les personnes âgées avec maladie oncologique [Cancer-related cognitive impairment in older adults] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.714.2172
Métriques
Partage / Export
Résumé
Chemotherapy is associated with transient or permanent cognitive dysfunction ranging from subjective complaints to measurable deficits in working memory, attention and language. Given that old age may be related to cognitive decline, the interaction between chemotherapy-induced cognitive impairment and the effects of age is of growing concern in view of our aging population. Chemotherapy-associated cognitive dysfunction may have an additive impact on pre-existing age-related cognitive performance decline, which calls for awareness in its detection, to reduce impact on quality of life and improve management of older patients. We discuss here the « chemobrain », concept, review the existing evidence about pathophysiology, neuroimaging and cognitive phenotype and propose practical tools for routine detection in the outpatient setting.